Pharmaceuticals, Biotechnology and Life Sciences
Conference call scheduled for 8:00 am ET on June 27, 2019 CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB: XCUR), a…
U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) voted to recommend HPV vaccination with GARDASIL
Veravas, Inc., an emerging diagnostic company, appointed eight members to its Advisory Board
DUBLIN–(BUSINESS WIRE)–The “Fotivda” report has been added to ResearchAndMarkets.com’s offering. Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) is an oral…
Phase 1/2 clinical trial to evaluate Intensity’s INT230-6 in combination with KEYTRUDA® (pembrolizumab) for multiple solid tumor types
Bioasis submitted to the FDA its pre-IND briefing document in support of the xB3-001 program for the treatment of patients with confirmed human epidermal growth factor receptor 2 (“HER2”)-positive (“HER2+”) breast cancer and brain metastases.
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF): To our shareholders, As we approach the end of Phase 2 development…
DUBLIN–(BUSINESS WIRE)–The “Bio Decontamination Market by Product (Equipment, Service, Consumables), Agent (Hydrogen Peroxide, Chlorine, Nitrogen, Peracetic Acid), Type, End User…
Joe O’Neill Announced as General Manager of Medison Canada PETACH TIKVA, Israel–(BUSINESS WIRE)–Medison Biotech (1995) Ltd. (“Medison”), today announced the…
TRCA-301E trial is the first, long-term, randomized, multicenter, blinded, placebo-controlled trial to evaluate the treatment of metabolic acidosis in patients…